Canada markets closed

Titan Medical Inc. (TMDIF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0350-0.0010 (-2.78%)
At close: 03:09PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.19M
Enterprise Value -2.03M
Trailing P/E 0.60
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.24
Price/Book (mrq)0.86
Enterprise Value/Revenue 0.39
Enterprise Value/EBITDA -0.60

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-76.47%
S&P500 52-Week Change 326.49%
52 Week High 30.1900
52 Week Low 30.0300
50-Day Moving Average 30.0490
200-Day Moving Average 30.0799

Share Statistics

Avg Vol (3 month) 3108.83k
Avg Vol (10 day) 355.79k
Shares Outstanding 5114.04M
Implied Shares Outstanding 6116.33M
Float 880.36M
% Held by Insiders 10.42%
% Held by Institutions 10.37%
Shares Short (Feb 28, 2023) 41.49M
Short Ratio (Feb 28, 2023) 40.16
Short % of Float (Feb 28, 2023) 41.33%
Short % of Shares Outstanding (Feb 28, 2023) 41.33%
Shares Short (prior month Jan 31, 2023) 4132.2k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:30
Last Split Date 3Jun 19, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 49.44%
Operating Margin (ttm)69.53%

Management Effectiveness

Return on Assets (ttm)136.53%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)17.63M
Revenue Per Share (ttm)0.17
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA 12.46M
Net Income Avi to Common (ttm)8.72M
Diluted EPS (ttm)0.0600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.71M
Total Cash Per Share (mrq)0.07
Total Debt (mrq)1.21M
Total Debt/Equity (mrq)32.00%
Current Ratio (mrq)3.12
Book Value Per Share (mrq)0.05

Cash Flow Statement

Operating Cash Flow (ttm)4.88M
Levered Free Cash Flow (ttm)2.08M